title: A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?
abstract: BACKGROUND
  Prognoses in STEMI and NSTEMI beyond one year from onset remain unclear. We aimed to compare the treatments and the two-year outcomes in patients with myocardial infarction (MI) enrolled at the Polish Registry of Acute Coronary Syndromes (PL-ACS).
  
  
  METHODS
  A total of 13,441 patients with MI (8250 with STEMI, and 5191 with NSTEMI) underwent medical care between October 2003 and June 2005 in the Silesia region (4.8 million inhabitants). The events analyzed were death, MI, stroke and percutaneous (PCI) or surgical (CABG) revascularization.
  
  
  RESULTS
  After two years, NSTEMI was associated with a higher incidence of death (hazard ratio (HR) of 1.09 (95% confidence interval (CI) 1.02-1.17, p<0.0001)); a higher incidence of reinfarction, stroke, CABG and a lower rate of PCI. Adjustments for baseline characteristics and treatment strategy (invasive vs. non-invasive) reversed the HR for mortality and eliminated the difference in MI and stroke. The adjusted HR for mortality was 0.76 (95% CI, 0.71-0.83, p<0.0001). STEMI and NSTEMI patients treated non-invasively were older and showed higher incidences of diabetes, obesity, pulmonary edema and cardiogenic shock than their invasively treated counterparts. Invasively treated patients received aspirin, beta-blockers, ACE inhibitors and statins more often during hospitalization and at discharge.
  
  
  CONCLUSIONS
  The unadjusted long-term prognosis was worse in NSTEMI. After adjustment for the baseline characteristics and treatment strategy, the long-term prognosis was worse in STEMI. Patients with MI treated invasively showed more favorable clinical characteristics and received guideline-recommended therapy more often than patients who did not undergo invasive treatment.
authors.affiliation: Silesian Centre for Heart Diseases, IIIrd Department of Cardiology, Medical Faculty in Zabrze, Medical University of Silesia, Poland.
authors.forename: Lech
authors.initials: L
authors.lastname: Polonski
authors.forename: Mariusz
authors.initials: M
authors.lastname: Gasior
authors.forename: Marek
authors.initials: M
authors.lastname: Gierlotka
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Osadnik
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Kalarus
authors.forename: Maria
authors.initials: M
authors.lastname: Trusz-Gluza
authors.forename: Marian
authors.initials: M
authors.lastname: Zembala
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Wilczek
authors.forename: Andrzej
authors.initials: A
authors.lastname: Lekston
authors.forename: Tomasz
authors.initials: T
authors.lastname: Zdrojewski
authors.forename: Michal
authors.initials: M
authors.lastname: Tendera
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000401:mortality / Q000601:surgery / Q000628:therapy; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000401:mortality; D001026:Coronary Artery Bypass / Q000401:mortality; D004562:Electrocardiography / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000401:mortality* / Q000601:surgery / Q000628:therapy; D011044:Poland / Q000453:epidemiology; D011237:Predictive Value of Tests; D011379:Prognosis; D012042:Registries / Q000706:statistics & numerical data*; D012307:Risk Factors; D020521:Stroke / Q000401:mortality; D016896:Treatment Outcome